Who owns DRUGS MADE IN AMER ACQUTN CO?
- Ticker: DMAAR
- CUSIP Number: g2847j112
Tip: Access positions for across all investors
Analyze quarterly positions in Drugs Made In Amer Acqutn with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Drugs Made In Amer Acqutn stock
Who bought or sold DRUGS MADE IN AMER ACQUTN CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Polar Securities | 1.9M | $209k | 0% | Jun 2026 |
|
| Highbridge Capital Management | 1.0M | $63k | 2% | Mar 2026 |
|
| Linden Advisors | 850k | $98k | 0% | Jun 2026 |
|
| Mangrove Partners | 850k | $94k | 0% | Jun 2026 |
|
| Toronto-Dominion Bank | 800k | $88k | 16% | Jun 2026 |
|
| Hudson Bay Capital Management | 759k | $84k | -55% | Jun 2026 |
|
| Clear Street Group | 711k | $78k | 0% | Jun 2026 |
|
| Boothbay Fund Management | 530k | $58k | -24% | Jun 2026 |
|
| Westchester Capital Management | 500k | $55k | 0% | Jun 2026 |
|
| LMR Partners | 500k | $55k | 0% | Jun 2026 |
|
| Alpine Partners VI | 500k | $55k | 38% | Jun 2026 |
|
| Wolverine Asset Management | 472k | $52k | -32% | Jun 2026 |
|
| Rivernorth Capital Management | 418k | $63k | 0% | Jun 2026 |
|
| Whitebox Advisors | 400k | $44k | 0% | Jun 2026 |
|
| CNH Partners | 372k | $37k | 0% | Jun 2026 |
|
| Shaolin Capital Management | 300k | $33k | -33% | Jun 2026 |
|
| Context Capital Management | 201k | $22k | 0% | Jun 2026 |
|
| Radcliffe Capital Management | 144k | $17k | -38% | Jun 2026 |
|
| DLD Asset Management | 127k | $14k | 25% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 120k | $13k | 0% | Jun 2026 |
|
| Periscope Capital | 75k | $8.3k | 0% | Jun 2026 |
|
| Lineage Point Capital | 50k | $5.5k | 0% | Jun 2026 |
|
| Gabelli Funds | 49k | $5.4k | 0% | Jun 2026 |
|
| Gabelli Securities | 48k | $5.3k | 0% | Jun 2026 |
|
| CSS | 31k | $28k | 0% | Jun 2026 |
|
| Readystate Asset Management | 31k | $3.4k | -38% | Jun 2026 |
|
| T3 Companies | 15k | $1.7k | 100% | Jun 2026 |
|
| UBS Group | 108.00 | $11.998800 | 100% | Jun 2026 |
|
Who sold out of Drugs Made In Amer Acqutn?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Mar 2026 | 1.0M | $63k |
| RLH Capital | Mar 2026 | 399k | $24k |
| Glazer Capital | Mar 2026 | 298k | $18k |
| Aristeia Capital | Mar 2026 | 264k | $16k |
| Quarry | Mar 2026 | 249k | $15k |
| Meteora Capital | Mar 2026 | 183k | $11k |
| Commonwealth of Pennsylvania | Mar 2026 | 118k | $7.1k |
| Verition Fund Management | Mar 2026 | 99k | $5.5k |
| Brooklyn Capital Management | Mar 2026 | 43k | $2.6k |
| Intl Fcstone | Mar 2026 | 42k | $2.5k |